Tissue Microarray Market Research Report - Global Forecast till 2023

Global Tissue Microarray Market: Information by Procedure (Immunohistochemistry, Fluorescent In-Situ Hybridization and Frozen Tissue Array), Technology (DNA Microarray, Polymerase Chain Reaction (PCR), Next-Generation Sequencing, Northern Blotting and Western Blotting), Application (Oncology, Gene Expression Profiling, SNP Detection, Double-Stranded B-DNA Microarrays, Comparative Genomic Hybridization and Sequencing Bioinformatics), End User (Pharmaceutical and Biotechnological Companies and Research Organization) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2023

ID: MRFR/LS/0706-CR | July 2019 | Region: Global | 186 pages

Overview


The Global Tissue Microarray Market is expected to register a CAGR of 10.54% and is anticipated to reach USD 10,914.54 million by 2023. Tissue microarrays are paraffin blocks that are created by separating cylindrical tissue cores from different paraffin donor blocks and re-embedding these into a microarray at defined array coordinates. With the help of tissue microarray, up to at least 1000 tissue samples can be arrayed into a single paraffin piece. It allows simultaneous analysis of molecules present in DNA, mRNA, and protein levels under identical, standardized conditions on a single glass slide. This adaptable strategy, in which data analysis is automated, facilitates retrospective and prospective human tissue studies.


The increasing application in drug discovery, increasing prevalence of cancer, growing advancements in biotechnology and pharmaceutical companies, and rising demand for cost-effective and accurate diagnostic methods are the major drivers propelling market growth. However, tissue microarray may not be fruitful for heterogeneous cancers, which is likely to constrain the growth of the market.


Market Dynamics


The prevalence of cancer is one of the crucial factors that drive the growth of the tissue microarray market. According to the American Cancer Society, in 2017, nearly 13% of all cancers diagnosed in adults aged 20. It further stated that rates of liver cancer, thyroid cancer, and melanoma are increasing from last few years. According to US Breast Cancer Statistics, about 1 in 8 US women (about 12%) will develop invasive breast cancer throughout their lifetime. In 2017, an estimated 252,710 new cases of invasive breast cancer were expected to be diagnosed in women in the US, along with 63,410 new cases of non-invasive (in-situ) breast cancer.


Moreover, increasing advancements in biotechnology and pharmaceutical companies and growing demand for cost-effective and accurate diagnostic methods have fueled the growth of the market. On the other hand, tissue microarray is that it may not be fruitful for heterogeneous cancers anticipated to hamper the market growth.


Global Tissue Microarray Market Size, by End User, 2016 (USD Million)
 Tissue Microarray Market


Source: MRFR Analysis


Segmentation


The global tissue microarray market has been divided into the procedure, technology, application, and end user. By procedure, the market has been segregated into immunohistochemistry, fluorescent in-situ hybridization, and frozen tissue array. Based on technology, the market has been segmented into DNA microarray, polymerase chain reaction (PCR), next-generation sequencing, northern blotting, and western blotting. Based on the application, the market has been bifurcated into oncology, gene expression profiling, SNP detection, double-stranded B-DNA microarrays, comparative genomic hybridization, and sequencing bioinformatics. By end-user, the market has been classified as pharmaceutical and biotechnological companies and research organization. The research organization segment accounted for a market value of USD 1876.02 million in 2016.


Key Players


The prominent players in the global tissue microarray market are Agilent Technologies, Illumina, Inc., Protein Biotechnologies Inc., Asterand Bioscience, Pantomics Inc., Applied Microarrays, Arrayit, Phalanx Biotech, QIAGEN, Takara Bio, Perkin Elmer, and Merck Sharp & Dohme Corp.


Some of the key strategies followed by the players operating in the global immunoassay in the R&D market were innovation, product development, acquisition, and expansion.


Asia-Pacific Tissue Microarray Market Share, by Country, 2016 (%)
 Tissue Microarray Market


Source: MRFR Analysis


Regional Analysis


The global tissue microarray market, based on region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is estimated to dominate the global tissue microarray market during the forecast period. This is attributed to the increase in the prevalence of cancer in the Americas, leading to the requirement for tissue microarrays. Besides, increasing application in drug discovery is also responsible for the growth of the market. Europe holds the second position in the market. Increasing emphasis on rapid diagnosis and treatment of cancer and infectious diseases, change in lifestyle, and high prevalence of cancer among geriatric population drives this market in Europe.


Additionally, the companies operating in the market are mainly focusing on mergers and acquisition, which is expected to support market growth. Asia-Pacific is expected to be the fastest-growing market for tissue microarray. Increasing prevalence of cancer, awareness among the people about their health, and changing lifestyle contribute to the growth of this market. In the Asia-Pacific region, China accounted for a market share of 21% in 2016. Furthermore, the market in the Middle East & Africa is expected to witness steady growth due to the lack of advanced medical facilities and less improvement in the healthcare domain.


Key Updates



  • In January 2017, Agilent technologies announced its collaboration with the Centre for Human Genetics of the University of Leuven and the University Hospital of Leuven in Belgium.



  • In July 2017, Horizon Discovery Group agreed to acquire GE Healthcare Dharmacon from parent General Electric for $85 million, creating a combined company focused on applying gene-editing and gene-modulation technologies in life science research.



  • In January 2017, Illumina Inc. announced the launch of Single-Cell Sequencing Solution in collaboration with Bio-Rad. It is the first Next-Generation Sequencing (NGS) workflow for single-cell analysis providing researchers the ability to investigate the coordinated contribution of individual cells in tissue function, disease progression, and therapeutic response.


Market Segmentation


Global Immunoassay in R&D Market, by Procedure



  • Immunohistochemistry

  • Fluorescent in Situ Hybridization

  • Frozen Tissue Array


Global Immunoassay in R&D Market, by Technology



  • DNA Microarray

  • Polymerase Chain Reaction (PCR)

  • Next-Generation Sequencing

  • Northern Blotting

  • Western Blotting


Global Immunoassay in R&D Market, by Application



  • Oncology

  • Gene Expression Profiling

  • SNP Detection

  • Double-Stranded B-DNA Microarrays

  • Comparative Genomic Hybridization

  • Sequencing Bioinformatics


Global Immunoassay in R&D Market, by End user



  • Pharmaceutical and Biotechnological Companies

  • Research Organization


Global Immunoassay in R&D Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • Latin America





  • Europe

    • Western Europe

      • Germany

      • UK

      • France

      • Italy

      • Spain

      • Rest of Western Europe



    • Eastern Europe





  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific





  • Middle East & Africa

    • Middle East

    • Africa




Available Additional Customizations



  • Pricing Analysis

  • Investment Opportunity Analysis

  • Merger & Acquisition Landscape


Intended Audience



  • Medical device manufacturers and distributors

  • Government research organizations

  • Hospitals and clinics

  • Regulatory agencies

  • Pharmaceutical companies



Frequently Asked Questions (FAQ) :


The valuation would be USD 10,914.54 million.

tissue microarray market CAGR would be 10.54% during the forecast period (2018-2024).

Increasing the use of drug discovery, the prevalence of cancer, better inclusion of biotechnology and pharmaceutical companies, and effective use of cost-effective and accurate diagnostic methods are the major drivers.

The Americas would enjoy the dominance in the tissue microarray market.

License

Single User Enterprise User (Buy Premium Reports Chapterwise)
Currency

USD YEN EURO GBP INR
TABLE OF CONTENT

2.1 Introduction 18

2.2 Scope of Study 18

2.3 Research Objective 18

2.4 Assumptions & Limitations 19

2.4.1 Assumptions 19

2.4.2 Limitations 19

2.5 Market Structure 20

3.1 Research Process 21

3.2 Market Size Estimation 23

3.2.1 Market Share analysis 23

3.3 Forecast Model 25

4.1 Drivers 26

4.1.1 Increasing application in drug discovery 26

4.1.2 Increasing prevalence of cancer 26

4.1.3 Increasing advancements in biotechnology and pharmaceutical companies 27

4.1.4 Increasing demand for cost-effective and accurate diagnostic methods 28

4.2 Restraints 28

4.2.1 Tissue microarray is that it may not be fruitful for heterogeneous cancers 28

4.3 Opportunities 28

4.4 Mega trends 29

4.4.1 Increasing use of sequence bioinformatics 29

4.5 Macroeconomic indicators 29

4.6 Technology Trends & Assessment 30

5.1 Porter’s Five Forces Model 31

5.1.1 Bargaining Power of Suppliers 31

5.1.2 Bargaining Power of Buyers 31

5.1.3 Threat of New Entrants 32

5.1.4 Threat of Substitutes 32

5.1.5 Intensity of Rivalry 32

5.2 Value Chain Analysis 33

5.2.1 R&D 33

5.2.2 Clinical Test & Legal Issues 33

5.2.3 Patenting & Manufacturing 34

5.2.4 Marketing & Sales 34

5.3 Pricing Analysis 34

5.4 Investment Opportunity Analysis 35

5.5 Merger & Acquisition Landscape 35

6.1 Introduction 37

6.2 Immunohistochemistry 38

6.3 Fluorescent In Situ Hybridization 39

6.4 Frozen Tissue Array 40

7.1 Introduction 41

7.2 DNA Microarray 43

7.3 Polymerase Chain Reaction (PCR) 44

7.4 Next-Generation Sequencing 45

7.5 Northern Blotting 46

7.6 Western Blotting 47

8.1 Introduction 48

8.2 Oncology 49

8.3 Gene Expression Profiling 50

8.4 SNP Detection 51

8.5 Double-Stranded B-DNA Microarrays 52

8.6 Comparative Genomic Hybridization 53

8.7 Sequencing Bioinformatics 54

9.1 Introduction 55

9.2 Pharmaceutical and Biotechnological Companies 56

9.3 Research Organization 57

10.1 Introduction 58

10.2 Americas 60

Tissue Microarray Market, By Procedure

Tissue Microarray Market, By Technology

Tissue Microarray Market, By Application

Tissue microarray Market, By End user

10.2.1 U.S. 64

Tissue Microarray Market, By Procedure

Tissue Microarray Market, By Technology

Tissue Microarray Market, By Application

Tissue microarray Market, By End user

10.2.2 Canada 67

Tissue Microarray Market, By Procedure

Tissue Microarray Market, By Technology

Tissue Microarray Market, By Application

Tissue microarray Market, By End user

10.2.3 South America 70

Tissue Microarray Market, By Procedure

Tissue Microarray Market, By Technology

Tissue Microarray Market, By Application

Tissue microarray Market, By End user

10.3 Europe 74

Tissue Microarray Market, By Procedure

Tissue Microarray Market, By Technology

Tissue Microarray Market, By Application

Tissue microarray Market, By End user

10.3.1 Germany 78

Tissue Microarray Market, By Procedure

Tissue Microarray Market, By Technology

Tissue Microarray Market, By Application

Tissue microarray Market, By End user

10.3.2 France 81

Tissue Microarray Market, By Procedure

Tissue Microarray Market, By Technology

Tissue Microarray Market, By Application

Tissue microarray Market, By End user

10.3.3 UK 84

Tissue Microarray Market, By Procedure

Tissue Microarray Market, By Technology

Tissue Microarray Market, By Application

Tissue microarray Market, By End user

10.3.4 Italy 87

Tissue Microarray Market, By Procedure

Tissue Microarray Market, By Technology

Tissue Microarray Market, By Application

Tissue microarray Market, By End user

10.3.5 Spain 90

Tissue Microarray Market, By Procedure

Tissue Microarray Market, By Technology

Tissue Microarray Market, By Application

Tissue microarray Market, By End user

10.3.6 Rest of Western Europe 93

Tissue Microarray Market, By Procedure

Tissue Microarray Market, By Technology

Tissue Microarray Market, By Application

Tissue microarray Market, By End user

10.3.7 Eastern Europe 96

Tissue Microarray Market, By Procedure

Tissue Microarray Market, By Technology

Tissue Microarray Market, By Application

Tissue microarray Market, By End user

10.4 Asia Pacific 100

Tissue Microarray Market, By Procedure

Tissue Microarray Market, By Technology

Tissue Microarray Market, By Application

Tissue microarray Market, By End user

10.4.1 Japan 104

Tissue Microarray Market, By Procedure

Tissue Microarray Market, By Technology

Tissue Microarray Market, By Application

Tissue microarray Market, By End user

10.4.2 China 107

Tissue Microarray Market, By Procedure

Tissue Microarray Market, By Technology

Tissue Microarray Market, By Application

Tissue microarray Market, By End user

10.4.3 India 110

Tissue Microarray Market, By Procedure

Tissue Microarray Market, By Technology

Tissue Microarray Market, By Application

Tissue microarray Market, By End user

10.4.4 Australia 113

Tissue Microarray Market, By Procedure

Tissue Microarray Market, By Technology

Tissue Microarray Market, By Application

Tissue microarray Market, By End user

10.4.5 Republic of Korea 116

Tissue Microarray Market, By Procedure

Tissue Microarray Market, By Technology

Tissue Microarray Market, By Application

Tissue microarray Market, By End user

10.4.6 Rest of Asia Pacific 119

Tissue Microarray Market, By Procedure

Tissue Microarray Market, By Technology

Tissue Microarray Market, By Application

Tissue microarray Market, By End user

10.5 Middle East & Africa 123

Tissue Microarray Market, By Procedure

Tissue Microarray Market, By Technology

Tissue Microarray Market, By Application

Tissue microarray Market, By End user

10.5.1 UAE 127

Tissue Microarray Market, By Procedure

Tissue Microarray Market, By Technology

Tissue Microarray Market, By Application

Tissue microarray Market, By End user

10.5.2 Saudi Arabia 130

Tissue Microarray Market, By Procedure

Tissue Microarray Market, By Technology

Tissue Microarray Market, By Application

Tissue microarray Market, By End user

10.5.3 Oman 133

Tissue Microarray Market, By Procedure

Tissue Microarray Market, By Technology

Tissue Microarray Market, By Application

Tissue microarray Market, By End user

10.5.4 Kuwait 136

Tissue Microarray Market, By Procedure

Tissue Microarray Market, By Technology

Tissue Microarray Market, By Application

Tissue microarray Market, By End user

10.5.5 Qatar 139

Tissue Microarray Market, By Procedure

Tissue Microarray Market, By Technology

Tissue Microarray Market, By Application

Tissue microarray Market, By End user

10.5.6 Rest of Middle East & Africa 142

Tissue Microarray Market, By Procedure

Tissue Microarray Market, By Technology

Tissue Microarray Market, By Application

Tissue microarray Market, By End user

11.1 Introduction 146

11.2 Company Share Analysis 146

12.1 Agilent Technologies 147

12.1.1 Company Overview 147

12.1.2 Product/Business Segment Overview 147

12.1.3 Financial Overview 148

12.1.4 Key Development 149

12.1.5 SWOT Analysis 150

12.2 Applied Microarrays 151

12.2.1 Overview 151

12.2.2 Product/Business Segment Overview 151

12.2.3 Financial Overview 151

12.2.4 Key Development 151

12.2.5 SWOT Analysis 151

12.3 Arrayit 153

12.3.1 Overview 153

12.3.2 Product/Business Segment Overview 153

12.3.3 Financial Overview 153

12.3.4 SWOT Analysis 154

12.4 Asterand Bioscience 155

12.4.1 Company Overview 155

12.4.2 Product/Business Segment Overview 155

12.4.3 Financial Overview 155

12.4.4 Key Developments 155

12.4.5 SWOT Analysis 156

12.5 Horizon Discovery 157

12.5.1 Overview 157

12.5.2 Product/Business Segment Overview 157

12.5.3 Financial Overview 157

12.5.4 Key Development 158

12.5.5 SWOT Analysis 159

12.6 Illumina Inc. 160

12.6.1 Company Overview 160

12.6.2 Product/Business Segment Overview 160

12.6.3 Financial Overview 161

12.6.4 Key Development 162

12.6.5 SWOT Analysis 163

12.7 Protein Biotechnologies Inc. 164

12.7.1 Company Overview 164

12.7.2 Product/Business Segment Overview 164

12.7.3 Financial Overview 165

12.7.4 Key Development 165

12.7.5 SWOT Analysis 165

12.8 Pantomics Inc. 166

12.8.1 Company Overview 166

12.8.2 Product/Business Segment Overview 166

12.8.3 Financial Overview 166

12.8.4 Key Development 166

12.8.5 SWOT Analysis 167

12.9 Phalanx Biotech Group 168

12.9.1 Overview 168

12.9.2 Product/Business Segment Overview 168

12.9.3 Financial Overview 168

12.9.4 Key Development 168

12.9.5 SWOT Analysis 169

12.10 Perkin Elmer 170

12.10.1 Overview 170

12.10.2 Product/Business Segment Overview 170

12.10.3 Financial Overview 170

12.10.4 Key Development 171

12.10.5 SWOT Analysis 172

12.11 QIAGEN 173

12.11.1 Company Overview 173

12.11.2 Product/Business Segment Overview 173

12.11.3 Financial Overview 173

12.11.4 Key Development 174

12.11.5 SWOT Analysis 175

12.12 SeraCare 176

12.12.1 Overview 176

12.12.2 Product/Business Segment Overview 176

12.12.3 Financial Overview 176

12.12.4 Key Development 177

12.12.5 SWOT Analysis 177

12.13 Takara Bio Inc. 178

12.13.1 Company Overview 178

12.13.2 Product/Business Segment Overview 178

12.13.3 Financial Overview 179

12.13.4 Key Development 180

12.13.5 SWOT Analysis 180

13.1 Key Findings 182

13.1.1 From CEO’s View Point 182

13.1.2 Unmet Needs 182

13.2 Key companies to watch 182



TABLE 1 MERGER AND ACQUISITION LANDSCAPE 35

TABLE 2 GLOBAL TISSUE MICROARRAY MARKET, BY PROCEDURE, 2014-2023 (USD MILLION) 37

TABLE 3 GLOBAL TISSUE MICROARRAY MARKET FOR IMMUNOHISTOCHEMISTRY, BY REGION, 2014-2023 (USD MILLION) 38

TABLE 4 GLOBAL TISSUE MICROARRAY MARKET FOR FLUORESCENT IN SITU HYBRIDIZATION, BY REGION, 2014-2023 (USD MILLION) 39

TABLE 5 GLOBAL TISSUE MICROARRAY MARKET FOR FROZEN TISSUE ARRAY, BY REGION, 2014-2023 (USD MILLION) 40

TABLE 6 GLOBAL TISSUE MICROARRAY MARKET, BY TECHNOLOGY, 2014-2023 (USD MILLION) 41

TABLE 7 GLOBAL TISSUE MICROARRAY MARKET FOR DNA MICROARRAY, BY REGION, 2014-2023 (USD MILLION) 43

TABLE 8 GLOBAL TISSUE MICROARRAY MARKET FOR POLYMERASE CHAIN REACTION (PCR), BY REGION, 2014-2023 (USD MILLION) 44

TABLE 9 GLOBAL TISSUE MICROARRAY MARKET FOR NEXT-GENERATION SEQUENCING, BY REGION, 2014-2023 (USD MILLION) 45

TABLE 10 GLOBAL TISSUE MICROARRAY MARKET FOR NORTHERN BLOTTING, BY REGION, 2014-2023 (USD MILLION) 46

TABLE 11 GLOBAL TISSUE MICROARRAY MARKET FOR WESTERN BLOTTING, BY REGION, 2014-2023 (USD MILLION) 47

TABLE 12 GLOBAL TISSUE MICROARRAY MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 48

TABLE 13 GLOBAL TISSUE MICROARRAY MARKET FOR ONCOLOGY, BY REGION, 2014-2023 (USD MILLION) 49

TABLE 14 GLOBAL TISSUE MICROARRAY MARKET FOR GENE EXPRESSION PROFILING, BY REGION, 2014-2023 (USD MILLION) 50

TABLE 15 GLOBAL TISSUE MICROARRAY MARKET FOR SNP DETECTION, BY REGION, 2014-2023 (USD MILLION) 51

TABLE 16 GLOBAL TISSUE MICROARRAY MARKET FOR DOUBLE-STRANDED B-DNA MICROARRAYS, BY REGION, 2014-2023 (USD MILLION) 52

TABLE 17 GLOBAL TISSUE MICROARRAY MARKET FOR COMPARATIVE GENOMIC HYBRIDIZATION, BY REGION, 2014-2023 (USD MILLION) 53

TABLE 18 GLOBAL TISSUE MICROARRAY MARKET FOR SEQUENCING BIOINFORMATICS , BY REGION, 2014-2023 (USD MILLION) 54

TABLE 19 GLOBAL TISSUE MICROARRAY MARKET, BY END USER, 2014-2023 (USD MILLION) 55

TABLE 20 GLOBAL TISSUE MICROARRAY MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES, BY REGION, 2014-2023 (USD MILLION) 56

TABLE 21 GLOBAL TISSUE MICROARRAY MARKET FOR RESEARCH ORGANIZATION, BY REGION, 2014-2023 (USD MILLION) 57

TABLE 22 GLOBAL TISSUE MICROARRAY MARKET, BY REGION, 2014-2023 (USD MILLION) 58

TABLE 23 AMERICAS TISSUE MICROARRAY MARKET, BY COUNTRY, 2014-2023 (USD MILLION) 60

TABLE 24 AMERICAS TISSUE MICROARRAY MARKET, BY PROCEDURE, 2014-2023 (USD MILLION) 61

TABLE 25 AMERICAS TISSUE MICROARRAY MARKET, BY TECHNOLOGY, 2014-2023 (USD MILLION) 62

TABLE 26 AMERICAS TISSUE MICROARRAY MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 63

TABLE 27 AMERICAS TISSUE MICROARRAY MARKET, BY END USER, 2014-2023 (USD MILLION) 64

TABLE 28 U.S. TISSUE MICROARRAY MARKET, BY PROCEDURE, 2014-2023 (USD MILLION) 64

TABLE 29 U.S. TISSUE MICROARRAY MARKET, BY TECHNOLOGY, 2014-2023 (USD MILLION) 65

TABLE 30 U.S. TISSUE MICROARRAY MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 66

TABLE 31 U.S. TISSUE MICROARRAY MARKET, BY END USER, 2014-2023 (USD MILLION) 67

TABLE 32 CANADA TISSUE MICROARRAY MARKET, BY PROCEDURE, 2014-2023 (USD MILLION) 67

TABLE 33 CANADA TISSUE MICROARRAY MARKET, BY TECHNOLOGY, 2014-2023 (USD MILLION) 68

TABLE 34 CANADA TISSUE MICROARRAY MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 69

TABLE 35 CANADA TISSUE MICROARRAY MARKET, BY END USER, 2014-2023 (USD MILLION) 70

TABLE 36 SOUTH AMERICA TISSUE MICROARRAY MARKET, BY PROCEDURE, 2014-2023 (USD MILLION) 70

TABLE 37 SOUTH AMERICA TISSUE MICROARRAY MARKET, BY TECHNOLOGY, 2014-2023 (USD MILLION) 71

TABLE 38 SOUTH AMERICA TISSUE MICROARRAY MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 72

TABLE 39 SOUTH AMERICA TISSUE MICROARRAY MARKET, BY END USER, 2014-2023 (USD MILLION) 73

TABLE 40 EUROPE TISSUE MICROARRAY MARKET, BY COUNTRY, 2014-2023 (USD MILLION) 74

TABLE 41 EUROPE TISSUE MICROARRAY MARKET, BY PROCEDURE, 2014-2023 (USD MILLION) 75

TABLE 42 EUROPE TISSUE MICROARRAY MARKET, BY TECHNOLOGY, 2014-2023 (USD MILLION) 76

TABLE 43 EUROPE TISSUE MICROARRAY MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 77

TABLE 44 EUROPE TISSUE MICROARRAY MARKET, BY END USER, 2014-2023 (USD MILLION) 78

TABLE 45 GERMANY TISSUE MICROARRAY MARKET, BY PROCEDURE, 2014-2023 (USD MILLION) 78

TABLE 46 GERMANY TISSUE MICROARRAY MARKET, BY TECHNOLOGY, 2014-2023 (USD MILLION) 79

TABLE 47 GERMANY TISSUE MICROARRAY MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 80

TABLE 48 GERMANY TISSUE MICROARRAY MARKET, BY END USER, 2014-2023 (USD MILLION) 81

TABLE 49 FRANCE TISSUE MICROARRAY MARKET, BY PROCEDURE, 2014-2023 (USD MILLION) 81

TABLE 50 FRANCE TISSUE MICROARRAY MARKET, BY TECHNOLOGY, 2014-2023 (USD MILLION) 82

TABLE 51 FRANCE TISSUE MICROARRAY MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 83

TABLE 52 FRANCE TISSUE MICROARRAY MARKET, BY END USER, 2014-2023 (USD MILLION) 84

TABLE 53 UK TISSUE MICROARRAY MARKET, BY PROCEDURE, 2014-2023 (USD MILLION) 84

TABLE 54 UK TISSUE MICROARRAY MARKET, BY TECHNOLOGY, 2014-2023 (USD MILLION) 85

TABLE 55 UK TISSUE MICROARRAY MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 86

TABLE 56 UK TISSUE MICROARRAY MARKET, BY END USER, 2014-2023 (USD MILLION) 87

TABLE 57 ITALY TISSUE MICROARRAY MARKET, BY PROCEDURE, 2014-2023 (USD MILLION) 87

TABLE 58 ITALY TISSUE MICROARRAY MARKET, BY TECHNOLOGY, 2014-2023 (USD MILLION) 88

TABLE 59 ITALY TISSUE MICROARRAY MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 89

TABLE 60 ITALY TISSUE MICROARRAY MARKET, BY END USER, 2014-2023 (USD MILLION) 90

TABLE 61 SPAIN TISSUE MICROARRAY MARKET, BY PROCEDURE, 2014-2023 (USD MILLION) 90

TABLE 62 SPAIN TISSUE MICROARRAY MARKET, BY TECHNOLOGY, 2014-2023 (USD MILLION) 91

TABLE 63 SPAIN TISSUE MICROARRAY MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 92

TABLE 64 SPAIN TISSUE MICROARRAY MARKET, BY END USER, 2014-2023 (USD MILLION) 93

TABLE 65 REST OF WESTERN EUROPE TISSUE MICROARRAY MARKET, BY PROCEDURE, 2014-2023 (USD MILLION) 93

TABLE 66 REST OF WESTERN EUROPE TISSUE MICROARRAY MARKET, BY TECHNOLOGY, 2014-2023 (USD MILLION) 94

TABLE 67 REST OF WESTERN EUROPE TISSUE MICROARRAY MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 95

TABLE 68 REST OF WESTERN EUROPE TISSUE MICROARRAY MARKET, BY END USER, 2014-2023 (USD MILLION) 96

TABLE 69 EASTERN EUROPE TISSUE MICROARRAY MARKET, BY PROCEDURE, 2014-2023 (USD MILLION) 96

TABLE 70 EASTERN EUROPE TISSUE MICROARRAY MARKET, BY TECHNOLOGY, 2014-2023 (USD MILLION) 97

TABLE 71 EASTERN EUROPE TISSUE MICROARRAY MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 98

TABLE 72 EASTERN EUROPE TISSUE MICROARRAY MARKET, BY END USER, 2014-2023 (USD MILLION) 99

TABLE 73 ASIA PACIFIC TISSUE MICROARRAY MARKET, BY COUNTRY, 2014-2023 (USD MILLION) 100

TABLE 74 ASIA PACIFIC TISSUE MICROARRAY MARKET, BY PROCEDURE, 2014-2023 (USD MILLION) 101

TABLE 75 ASIA PACIFIC TISSUE MICROARRAY MARKET, BY TECHNOLOGY, 2014-2023 (USD MILLION) 102

TABLE 76 ASIA PACIFIC TISSUE MICROARRAY MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 103

TABLE 77 ASIA PACIFIC TISSUE MICROARRAY MARKET, BY END USER, 2014-2023 (USD MILLION) 104

TABLE 78 JAPAN TISSUE MICROARRAY MARKET, BY PROCEDURE, 2014-2023 (USD MILLION) 104

TABLE 79 JAPAN TISSUE MICROARRAY MARKET, BY TECHNOLOGY, 2014-2023 (USD MILLION) 105

TABLE 80 JAPAN TISSUE MICROARRAY MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 106

TABLE 81 JAPAN TISSUE MICROARRAY MARKET, BY END USER, 2014-2023 (USD MILLION) 107

TABLE 82 CHINA TISSUE MICROARRAY MARKET, BY PROCEDURE, 2014-2023 (USD MILLION) 107

TABLE 83 CHINA TISSUE MICROARRAY MARKET, BY TECHNOLOGY, 2014-2023 (USD MILLION) 108

TABLE 84 CHINA TISSUE MICROARRAY MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 109

TABLE 85 CHINA TISSUE MICROARRAY MARKET, BY END USER, 2014-2023 (USD MILLION) 110

TABLE 86 INDIA TISSUE MICROARRAY MARKET, BY PROCEDURE, 2014-2023 (USD MILLION) 110

TABLE 87 INDIA TISSUE MICROARRAY MARKET, BY TECHNOLOGY, 2014-2023 (USD MILLION) 111

TABLE 88 INDIA TISSUE MICROARRAY MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 112

TABLE 89 INDIA TISSUE MICROARRAY MARKET, BY END USER, 2014-2023 (USD MILLION) 113

TABLE 90 AUSTRALIA TISSUE MICROARRAY MARKET, BY PROCEDURE, 2014-2023 (USD MILLION) 113

TABLE 91 AUSTRALIA TISSUE MICROARRAY MARKET, BY TECHNOLOGY, 2014-2023 (USD MILLION) 114

TABLE 92 AUSTRALIA TISSUE MICROARRAY MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 115

TABLE 93 AUSTRALIA TISSUE MICROARRAY MARKET, BY END USER, 2014-2023 (USD MILLION) 116

TABLE 94 REPUBLIC OF KOREA TISSUE MICROARRAY MARKET, BY PROCEDURE, 2014-2023 (USD MILLION) 116

TABLE 95 REPUBLIC OF KOREA TISSUE MICROARRAY MARKET, BY TECHNOLOGY, 2014-2023 (USD MILLION) 117

TABLE 96 REPUBLIC OF KOREA TISSUE MICROARRAY MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 118

TABLE 97 REPUBLIC OF KOREA TISSUE MICROARRAY MARKET, BY END USER, 2014-2023 (USD MILLION) 119

TABLE 98 REST OF ASIA PACIFIC TISSUE MICROARRAY MARKET, BY PROCEDURE, 2014-2023 (USD MILLION) 119

TABLE 99 REST OF ASIA PACIFIC TISSUE MICROARRAY MARKET, BY TECHNOLOGY, 2014-2023 (USD MILLION) 120

TABLE 100 REST OF ASIA PACIFIC TISSUE MICROARRAY MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 121

TABLE 101 REST OF ASIA PACIFIC TISSUE MICROARRAY MARKET, BY END USER, 2014-2023 (USD MILLION) 122

TABLE 102 MIDDLE EAST & AFRICA TISSUE MICROARRAY MARKET, BY COUNTRY, 2014-2023 (USD MILLION) 123

TABLE 103 MIDDLE EAST & AFRICA TISSUE MICROARRAY MARKET, BY PROCEDURE, 2014-2023 (USD MILLION) 124

TABLE 104 MIDDLE EAST & AFRICA TISSUE MICROARRAY MARKET, BY TECHNOLOGY, 2014-2023 (USD MILLION) 125

TABLE 105 MIDDLE EAST & AFRICA TISSUE MICROARRAY MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 126

TABLE 106 MIDDLE EAST & AFRICA TISSUE MICROARRAY MARKET, BY END USER, 2014-2023 (USD MILLION) 127

TABLE 107 UAE TISSUE MICROARRAY MARKET, BY PROCEDURE, 2014-2023 (USD MILLION) 127

TABLE 108 UAE TISSUE MICROARRAY MARKET, BY TECHNOLOGY, 2014-2023 (USD MILLION) 128

TABLE 109 UAE TISSUE MICROARRAY MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 129

TABLE 110 UAE TISSUE MICROARRAY MARKET, BY END USER, 2014-2023 (USD MILLION) 130

TABLE 111 SAUDI ARABIA TISSUE MICROARRAY MARKET, BY PROCEDURE, 2014-2023 (USD MILLION) 130

TABLE 112 SAUDI ARABIA TISSUE MICROARRAY MARKET, BY TECHNOLOGY, 2014-2023 (USD MILLION) 131

TABLE 113 SAUDI ARABIA TISSUE MICROARRAY MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 132

TABLE 114 SAUDI ARABIA TISSUE MICROARRAY MARKET, BY END USER, 2014-2023 (USD MILLION) 133

TABLE 115 OMAN TISSUE MICROARRAY MARKET, BY PROCEDURE, 2014-2023 (USD MILLION) 133

TABLE 116 OMAN TISSUE MICROARRAY MARKET, BY TECHNOLOGY, 2014-2023 (USD MILLION) 134

TABLE 117 OMAN TISSUE MICROARRAY MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 135

TABLE 118 OMAN TISSUE MICROARRAY MARKET, BY END USER, 2014-2023 (USD MILLION) 136

TABLE 119 KUWAIT TISSUE MICROARRAY MARKET, BY PROCEDURE, 2014-2023 (USD MILLION) 136

TABLE 120 KUWAIT TISSUE MICROARRAY MARKET, BY TECHNOLOGY, 2014-2023 (USD MILLION) 137

TABLE 121 KUWAIT TISSUE MICROARRAY MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 138

TABLE 122 KUWAIT TISSUE MICROARRAY MARKET, BY END USER, 2014-2023 (USD MILLION) 139

TABLE 123 QATAR TISSUE MICROARRAY MARKET, BY PROCEDURE, 2014-2023 (USD MILLION) 139

TABLE 124 QATAR TISSUE MICROARRAY MARKET, BY TECHNOLOGY, 2014-2023 (USD MILLION) 140

TABLE 125 QATAR TISSUE MICROARRAY MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 141

TABLE 126 QATAR TISSUE MICROARRAY MARKET, BY END USER, 2014-2023 (USD MILLION) 142

TABLE 127 REST OF MIDDLE EAST & AFRICA TISSUE MICROARRAY MARKET, BY PROCEDURE, 2014-2023 (USD MILLION) 142

TABLE 128 REST OF MIDDLE EAST & AFRICA TISSUE MICROARRAY MARKET, BY TECHNOLOGY, 2014-2023 (USD MILLION) 143

TABLE 129 REST OF MIDDLE EAST & AFRICA TISSUE MICROARRAY MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 144

TABLE 130 REST OF MIDDLE EAST & AFRICA TISSUE MICROARRAY MARKET, BY END USER, 2014-2023 (USD MILLION) 145

TABLE 131 AGILENT TECHNOLOGIES: KEY DEVELOPMENT 149

TABLE 132 APPLIED MICROARRAYS: KEY DEVELOPMENT 151

TABLE 133 HORIZON DISCOVERY: KEY DEVELOPMENT 158

TABLE 134 ILLUMINA INC: KEY DEVELOPMENT 162

TABLE 135 PHALANX BIOTECH GROUP: KEY DEVELOPMENT 168

TABLE 136 PERKIN ELMER: KEY DEVELOPMENT 171

TABLE 137 QIAGEN: KEY DEVELOPMENT 174

TABLE 138 SERACARE: KEY DEVELOPMENT 177

TABLE 139 TAKARA BIO INC: KEY DEVELOPMENT 180

FIGURE 1 GLOBAL TISSUE MICROARRAY MARKET, BY PROCEDURE, 2016 (%) 15

FIGURE 2 GLOBAL TISSUE MICROARRAY MARKET, BY TECHNOLOGY, 2016 (%) 15

FIGURE 3 GLOBAL TISSUE MICROARRAY MARKET, BY APPLICATION, 2016 (%) 16

FIGURE 4 GLOBAL TISSUE MICROARRAY MARKET, BY END USER, 2016 (%) 16

FIGURE 5 GLOBAL TISSUE MICROARRAY MARKET, BY REGION, 2016 (%) 17

FIGURE 6 GLOBAL TISSUE MICROARRAY MARKET: MARKET STRUCTURE 20

FIGURE 7 RESEARCH PROCESS 21

FIGURE 8 MARKET ASSESMENT: TRAIGULATION APPROACH 22

FIGURE 9 GLOBAL TISSUE MICROARRAY MARKET: FORECAST MODEL 25

FIGURE 10 PORTERS FIVE FORCES MODEL 31

FIGURE 11 VALUE CHAIN: TISSUE MICROARRAY 33

FIGURE 12 GLOBAL TISSUE MICROARRAY MARKET, BY PROCEDURE, 2016 & 2023 (%) 38

FIGURE 13 GLOBAL TISSUE MICROARRAY MARKET, BY TECHNOLOGY, 2016 & 2023 (USD MILLION) 42

FIGURE 14 GLOBAL TISSUE MICROARRAY MARKET, BY APPLICATION, 2016 & 2023 (%) 48

FIGURE 15 GLOBAL TISSUE MICROARRAY MARKET, BY END USER, 2016 & 2023 (%) 56

FIGURE 16 GLOBAL TISSUE MICROARRAY MARKET, BY REGION, 2016 & 2023 (USD MILLION) 59

FIGURE 17 AMERICAS TISSUE MICROARRAY MARKET, BY COUNTRY, 2016 & 2023 (USD MILLION) 61

FIGURE 18 EUROPE TISSUE MICROARRAY MARKET, BY COUNTRY, 2016 & 2023 (USD MILLION) 75

FIGURE 19 ASIA PACIFIC TISSUE MICROARRAY MARKET, BY COUNTRY, 2016 & 2023 (USD MILLION) 101

FIGURE 21 MIDDLE EAST & AFRICA TISSUE MICROARRAY MARKET, BY COUNTRY, 2016 & 2023 (USD MILLION) 124

FIGURE 22 GLOBAL TISSUE MICROARRAY MARKET: COMPANY SHARE ANALYSIS 146

FIGURE 23 AGILENT TECHNOLOGIES: RECENT FINANCIALS 148

FIGURE 24 AGILENT: OPERATING SEGMENTS, 2016 (%) 149

FIGURE 25 AGILENT TECHNOLOGIES: GEOGRAPHIC MIX, 2016 (%) 149

FIGURE 26 AGILENT TECHNOLOGIES: SWOT ANALYSIS 150

FIGURE 27 APPLIED MICROARRAYS: SWOT ANALYSIS 151

FIGURE 28 ARRAYIT: SWOT ANALYSIS 154

FIGURE 29 ASTERAND: SWOT ANALYSIS 156

FIGURE 30 HORIZON DISCOVERY: RECENT FINANCIAL 157

FIGURE 31 HORIZON DISCOVERY: GEOGRAPHIC MIX, 2016 (%) 158

FIGURE 32 HORIZON DISCOVERY: SWOT ANALYSIS 159

FIGURE 33 ILLUMINA INC.: RECENT FINANCIALS 161

FIGURE 34 ILLUMINA INC: GEOGRAPHICAL MIX, 2016 (%) 161

FIGURE 35 ILLUMINA INC: SEGMENTAL MIX, 2016 (%) 162

FIGURE 36 ILLUMINA INC: SWOT ANALYSIS 163

FIGURE 37 PROTEIN BIOTECHNOLOGIES INC: SWOT ANALYSIS 165

FIGURE 38 PANTOMICS INC.: SWOT ANALYSIS 167

FIGURE 39 PHALANX BIOTECH GROUP: SWOT ANALYSIS 169

FIGURE 40 PERKIN ELMER: RECENT FINANCIAL 170

FIGURE 41 PERKIN ELMER: GEOGRAPHIC REVENUE MIX 170

FIGURE 42 PERKIN ELMER: SWOT ANALYSIS 172

FIGURE 43 QIAGEN N.V.: RECENT FINANCIALS 173

FIGURE 44 QIAGEN N.V.: SEGMENT MIX, 2016 (%) 174

FIGURE 45 QIAGEN N.V.: GEOGRAPHIC MIX, 2016 (%) 174

FIGURE 46 QIAGEN N.V.: SWOT ANALYSIS 175

FIGURE 47 SERACARE: SWOT ANALYSIS 177

FIGURE 48 TAKARA BIO INC.: RECENT FINANCIAL 179

FIGURE 49 TAKARA BIO INC.: BUSINESS REVENUE MIX (2015) 180

FIGURE 50 TAKARA BIO INC.: GEOGRAPHIC REVENUE MIX 180

FIGURE 51 TAKARA BIO INC: SWOT ANALYSIS 180